Minimal residual disease diagnostics in myeloid malignancies in the post transplant period

U Bacher, AR Zander, T Haferlach… - Bone marrow …, 2008 - nature.com
Allogeneic SCT is important in myelodysplastic syndrome, the BCR-ABL-negative chronic
myeloproliferative diseases (CMPDs) and in poor-risk AML. Techniques to monitor the …
被引用次数：44 相关文章

Minimal residual disease diagnostics in myeloid malignancies in the post transplant period

U Bacher, AR Zander, T Haferlach… - Bone Marrow …, 2008 - go.gale.com
Allogeneic SCT is important in myelodysplastic syndrome, the BCR-ABL-negative chronic
myeloproliferative diseases (CMPDs) and in poor-risk AML. Techniques to monitor the …

Minimal residual disease diagnostics in myeloid malignancies in the post transplant period.

U Bacher, AR Zander, T Haferlach… - Bone Marrow …, 2008 - europepmc.org
Allogeneic SCT is important in myelodysplastic syndrome, the BCR-ABL-negative chronic
myeloproliferative diseases (CMPDs) and in poor-risk AML. Techniques to monitor the …

Minimal residual disease diagnostics in myeloid malignancies in the post transplant period

U Bacher, AR Zander, T Haferlach… - Bone marrow …, 2008 - pubmed.ncbi.nlm.nih.gov
Allogeneic SCT is important in myelodysplastic syndrome, the BCR-ABL-negative chronic
myeloproliferative diseases (CMPDs) and in poor-risk AML. Techniques to monitor the …

Minimal residual disease diagnostics in myeloid malignancies in the post transplant period.

U Bacher, AR Zander, T Haferlach… - Bone Marrow …, 2008 - search.ebscohost.com
Allogeneic SCT is important in myelodysplastic syndrome, the BCR-ABL-negative chronic
myeloproliferative diseases (CMPDs) and in poor-risk AML. Techniques to monitor the …

[引用][C] Minimal residual disease diagnostics in myeloid malignancies in the post transplant period

U BACHER, AR ZANDER… - Bone marrow …, 2008 - pascal-francis.inist.fr
Minimal residual disease diagnostics in myeloid malignancies in the post transplant period
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …
[PDF] researchgate.net

[PDF][PDF] Minimal residual disease diagnostics in myeloid malignancies in the post transplant period

U Bacher, AR Zander, T Haferlach… - Bone Marrow …, 2008 - researchgate.net
In contrast to CML with its rather homogeneous profile due to the BCR-ABL fusion all other
myeloid malignancies, AML, myelodysplastic syndrome (MDS) and the BCR-ABL-negative …

[引用][C] Minimal residual disease diagnostics in myeloid malignancies in the post transplant period

U Bacher, AR Zander, T Haferlach… - Bone Marrow …, 2008 - cir.nii.ac.jp
Minimal residual disease diagnostics in myeloid malignancies in the post transplant period |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォーム …

[引用][C] Minimal residual disease diagnostics in myeloid malignancies in the post transplant period

U BACHER, AR ZANDER… - Bone marrow …, 2008 - Nature Publishing Group

[引用][C] Minimal residual disease diagnostics in myeloid malignancies in the post transplant period

U Bacher, AR Zander, T Haferlach… - Bone Marrow …, 2008 - Nature Publishing Group